View Section: Financials
Orion Biotech Statements
OR
Orion Biotech Income Statement
B
M
USD (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
2022-12-31
%
—
100
—
0
—
0
—
0
0.204
0
0.204
0
-0.204
0
1.492
0
—
0
1.288
0
—
0
1.288
0
0.052
25
2022-09-30
%
—
100
—
0
—
0
—
0
0.205
0
0.205
0
-0.205
0
1.126
0
—
0
0.92
0
—
0
0.92
0
0.037
25
2022-06-30
%
—
100
—
0
—
0
—
0
0.205
0
0.205
0
-0.205
0
2.134
0
—
0
1.929
0
—
0
1.929
0
0.077
25
2022-03-31
%
—
100
—
0
—
0
—
0
0.286
0
0.286
0
-0.286
0
4.904
0
—
0
4.618
0
—
0
4.618
0
0.185
25
2021-12-31
%
—
100
—
0
—
0
—
0
0.205
0
0.205
0
-0.205
0
-0.691
0
—
0
-0.896
0
—
0
-0.896
0
-0.036
24.72
2021-09-30
%
—
100
—
0
—
0
—
0
0.224
0
0.224
0
-0.224
0
2.489
0
—
0
2.264
0
—
0
2.264
0
0.091
25
2021-06-30
%
—
100
—
0
—
0
—
0
—
0
0.154
0
-0.154
0
—
0
-1.894
0
-2.048
0
—
0
-2.048
0
-0.082
25
2021-03-31
%
—
100
—
0
—
0
—
0
0.045
0
0.045
0
-0.045
0
—
0
—
0
-0.045
0
—
0
-0.045
0
-0.002
25.75
View Section: Balance Sheet